PhD student at First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China
Chenyang Fan is a dedicated PhD student at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, contributing to the National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion. Her academic journey spans over five years, during which she has remained focused on the prevention and treatment of hematological tumors by integrating traditional Chinese medicine (TCM) with Western medicine. With a strong inclination toward evidence-based research, she has successfully navigated both academic and applied aspects of integrative medicine. Her early engagement with clinical and molecular research methodologies has set a strong foundation for her academic growth and scientific contribution, making her a promising researcher in the field of hematologic oncology.
Profile
Scopus
Education:
Chenyang Fan is currently pursuing her doctoral degree at Tianjin University of Traditional Chinese Medicine, a prestigious institution known for its contribution to both traditional and integrative medical science. Her academic background reflects a blend of rigorous scientific methodology and holistic medical philosophy. This educational foundation has empowered her to delve into cross-disciplinary research, enabling her to evaluate therapeutic mechanisms using both pharmacological validation and traditional diagnostic paradigms. Her training has allowed her to understand the biological complexities of hematological cancers, while also appreciating the systemic perspective offered by TCM.
Experience:
In her academic and research trajectory, Chenyang Fan has demonstrated an exceptional capacity for leading and contributing to major scientific initiatives. She has served as the principal investigator of one university-level project and has been actively involved in five provincial and ministerial-level projects. These projects, often involving collaboration across institutions and disciplines, focused on the integration of Chinese and Western medical approaches for the management of hematologic malignancies. Furthermore, she co-edited a scholarly book and has worked on research funded by the Tianjin Municipal Health Commission and National Center for Clinical Medical Research, reflecting a balanced involvement in both institutional research and public health-related investigations. Her ability to contribute across project stages—from experimental design to data analysis and dissemination—demonstrates her holistic research competence.
Research Interest:
Chenyang Fan’s research interests lie at the intersection of hematological oncology and integrative medical therapies. She is particularly focused on investigating the molecular mechanisms, immune interactions, and therapeutic pathways underlying leukemia, lymphoma, multiple myeloma, and immune thrombocytopenia. Her methodological approach often combines modern techniques such as network pharmacology and Mendelian randomization with classical Chinese medicine theory, allowing her to explore disease etiology and treatment efficacy from dual perspectives. Her work aims to bridge the gaps between clinical observations and experimental findings, thus establishing a translational pipeline from traditional medicine practices to modern oncology treatments.
Award:
Chenyang Fan’s commitment to scientific excellence and clinical relevance is reflected in her nomination for the Best Researcher Award under the International Research Awards on Fiber Reinforced Polymer. This acknowledgment stems from her cumulative achievements in high-impact research, her involvement in government-funded medical research initiatives, and her scholarly publications in internationally recognized journals. Her unique focus on integrating holistic medicine with rigorous scientific validation addresses a pressing global need for personalized, sustainable, and effective cancer treatment approaches. Her contribution adds a valuable dimension to the field of translational medicine and integrative oncology.
Publication:
Chenyang Fan has authored several impactful scientific papers in internationally peer-reviewed journals. Among her recent works:
-
Fan C, Yang X, Yan L, Shi Z. (2024). Oxidative stress is two-sided in the treatment of acute myeloid leukemia. Cancer Med; 13(9): e6806. Cited by 11 articles.
-
Fan C et al. (2024). Metabolite, immunocyte phenotype, and lymphoma: a Mendelian randomization study. Front Immunol; 15: 1431261. Cited by 9 articles.
-
Yang X et al., including Fan C. (2024). Mechanism of Zhengsui Wan in the Treatment of Acute Lymphoblastic Leukemia. Curr Stem Cell Res Ther. Cited by 6 articles.
-
Jia Y et al., including Fan C. (2025). Progress of immune senescence in multiple myeloma treatment resistance. Discov Oncol; 16(1): 402. Cited by 5 articles.
-
Zhu G et al., including Fan C. (2024). Possible immune mechanisms of gut microbiota in immune thrombocytopenia. Front Microbiol; 15: 1426911. Cited by 7 articles.
These publications underscore her interest in immune modulation, systems pharmacology, and clinical validation in hematologic diseases, demonstrating scholarly rigor and clinical relevance.
Conclusion:
Chenyang Fan exemplifies the qualities of a forward-thinking and deeply committed researcher. Her interdisciplinary perspective, grounded in both traditional medicine and modern biomedical science, sets her apart as a unique contributor to the evolving landscape of cancer therapy. She has demonstrated consistency in academic output, leadership in collaborative projects, and a growing influence in the scientific community through her publications and presentations. Her work is timely and impactful, addressing global challenges in cancer care using culturally contextual and scientifically validated methodologies. Based on her academic merit, research innovation, and publication impact, Chenyang Fan is an excellent nominee for the Best Researcher Award and a rising star in integrative oncology research.